Human IgG4: a structural perspective

被引:134
作者
Davies, Anna M. [1 ,2 ,3 ]
Sutton, Brian J. [1 ,2 ,3 ]
机构
[1] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[2] MRC, London, England
[3] Asthma UK Ctr Allerg Mech Asthma, London, England
基金
英国医学研究理事会;
关键词
immunoglobulin; antibody; IgG4; IgG1; Fc receptor; FC-GAMMA RECEPTORS; FAB-ARM EXCHANGE; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; RHEUMATOID-ARTHRITIS; EFFECTOR FUNCTIONS; B-CELLS; AFFINITY RECEPTOR; BINDING-SITE; EPSILON-RI;
D O I
10.1111/imr.12349
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IgG4, the least represented human IgG subclass in serum, is an intriguing antibody with unique biological properties, such as the ability to undergo Fab-arm exchange and limit immune complex formation. The lack of effector functions, such as antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity, is desirable for therapeutic purposes. IgG4 plays a protective role in allergy by acting as a blocking antibody, and inhibiting mast cell degranulation, but a deleterious role in malignant melanoma, by impeding IgG1-mediated anti-tumor immunity. These findings highlight the importance of understanding the interaction between IgG4 and Fc receptors. Despite a wealth of structural information for the IgG1 subclass, including complexes with Fc receptors, and structures for intact antibodies, high-resolution crystal structures were not reported for IgG4-Fc until recently. Here, we highlight some of the biological properties of human IgG4, and review the recent crystal structures of IgG4-Fc. We discuss the unexpected conformations adopted by functionally important C2 domain loops, and speculate about potential implications for the interaction between IgG4 and FcRs.
引用
收藏
页码:139 / 159
页数:21
相关论文
共 168 条
[1]   Immunoglobulin G4: an odd antibody [J].
Aalberse, R. C. ;
Stapel, S. O. ;
Schuurman, J. ;
Rispens, T. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (04) :469-477
[2]   IgG4 breaking the rules [J].
Aalberse, RC ;
Schuurman, J .
IMMUNOLOGY, 2002, 105 (01) :9-19
[3]  
AALBERSE RC, 1983, J IMMUNOL, V130, P722
[4]   Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy [J].
Abe, Yuki ;
Gor, Jayesh ;
Bracewell, Daniel G. ;
Perkins, Stephen J. ;
Dalby, Paul A. .
BIOCHEMICAL JOURNAL, 2010, 432 :101-111
[5]   Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins [J].
Ahmed, Alysia A. ;
Giddens, John ;
Pincetic, Andrew ;
Lomino, Joseph V. ;
Ravetch, Jeffrey V. ;
Wang, Lai-Xi ;
Bjorkman, Pamela J. .
JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (18) :3166-3179
[6]   A SINGLE AMINO-ACID SUBSTITUTION ABOLISHES THE HETEROGENEITY OF CHIMERIC MOUSE/HUMAN (IGG4) ANTIBODY [J].
ANGAL, S ;
KING, DJ ;
BODMER, MW ;
TURNER, A ;
LAWSON, ADG ;
ROBERTS, G ;
PEDLEY, B ;
ADAIR, JR .
MOLECULAR IMMUNOLOGY, 1993, 30 (01) :105-108
[7]  
[Anonymous], PYMOL MOL GRAPH SYST
[8]   A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs [J].
Anthony, Robert M. ;
Ravetch, Jeffrey V. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 :S9-S14
[9]  
Bloom JW, 1997, PROTEIN SCI, V6, P407
[10]   THE STRUCTURAL REQUIREMENTS FOR COMPLEMENT ACTIVATION BY IGG - DOES IT HINGE ON THE HINGE [J].
BREKKE, OH ;
MICHAELSEN, TE ;
SANDLIE, I .
IMMUNOLOGY TODAY, 1995, 16 (02) :85-90